AlphaFold predicted structure
ABAT · P80404

Mean pLDDT
93.8/ 100
Very high
500 residues
Confidence breakdown
- Very high(≥ 90)92%
- Confident(70–90)0%
- Low(50–70)0%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
4-aminobutyrate aminotransferase
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Childhood onset dystonia, chorea or related movement disorder
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalMitochondrial DNA maintenance disorder
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomal+2 more panels — install the extension to see the full list inline on any page.
Gamma-aminobutyric acid transaminase deficiency
GABA aminotransaminase deficiency
infantile spasms
mitochondrial DNA depletion syndrome
epilepsy
Focal impaired awareness seizure
complex partial epilepsy
Global developmental delay
focal epilepsy
hereditary disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
4-aminobutyrate aminotransferase, mitochondrial
Catalyzes the conversion of gamma-aminobutyrate and L-beta-aminoisobutyrate to succinate semialdehyde and methylmalonate semialdehyde, respectively (PubMed:10407778, PubMed:15528998). Can also convert delta-aminovalerate and beta-alanine (By similarity)
ABAT · P80404

Mean pLDDT
93.8/ 100
Very high
500 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0